A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
hookworm
Researchers Analyze Genomes of 81 Parasitic Worm Species
Ashley P. Taylor | Nov 5, 2018 | 2 min read
The new data could help identify treatments for diseases ranging from river blindness to schistosomiasis.
Image of the Day: Hungry Hookworms
The Scientist and The Scientist Staff | Mar 26, 2018 | 1 min read
Researchers discover anti-malarials called quinolones can halt the development of the parasites, offering a potential therapeutic avenue.
Genome Digest
Jenny Rood | Mar 4, 2015 | 6 min read
What researchers are learning as they sequence, map, and decode species’ genomes